On a GLP-1, you're not choosing to under-eat protein the medication makes it easy to forget to eat or default to whatever's easiest
If any blood appears on the skin, press lightly with a gauze pad or cotton ball
For those in a maintenance phase after weight loss, microdosing can help preserve metabolic gains without the appetite suppression of higher doses, prioritizing sustainability , tolerability , and resilience important for long-term health optimization
In addition to activating expression of the S100G (CALB3) gene in the intestine, calcitriol also enhances the expression of several intestinal calcium transporter genes including the TRPV6 gene (encoding the transient receptor potential vanilloid 6 transporter), the SLC8A1 gene (encoding the Na + -Ca 2+ exchanger
doi:10.36849/JDD.8605 INTRODUCTION Glucagon-like peptide-1 (GLP-1) agonists are used to treat type 2 diabetes mellitus (T2DM) and have recently gained approval and popularity for treating obesity and weight loss
The most common side effects of injectable tirzepatide include nausea, diarrhoea, vomiting, decreased appetite, abdominal discomfort, constipation, and dyspepsia